Skip to main content
Top
Published in: Seminars in Immunopathology 4/2022

Open Access 01-07-2022 | Primary Sclerosing Cholangitis | Introduction

Tolerance and autoimmunity in the liver

Authors: Christoph Schramm, Ye H. Oo, Ansgar W. Lohse

Published in: Seminars in Immunopathology | Issue 4/2022

Login to get access

Excerpt

Autoimmune diseases arise from the failure of immune tolerance towards self-antigens. In the liver, maintenance of immune tolerance is particularly challenging. The liver filters all blood from the intestinal tract and is thus exposed to an infinite number of nutritional and microbial antigens. Additionally, the liver harbours the large mucosal surface of the biliary system which is colonized with microbiota and exposed to environmental factors. Together with neo-antigens arising from hepatic metabolism, the liver therefore is constantly challenged to maintain tolerance against harmless antigens and to rise immune responses against harmful environmental exposure. It is presumably for this reason that the liver microenvironment—under normal circumstances—is a particularly potent inducer of immune tolerance within the organ itself, but also systemically. For example, targeting liver sinusoidal endothelial cells using nanoparticles revealed that these cells can be harnessed to induce tolerance to the central nervous system autoantigen myelin basic protein, which can prevent the development of experimental autoimmune encephalomyelitis [1]. While the tolerogenic liver microenvironment prevents immune attack in the healthy liver, it presumably also provides a survival benefit for cancer cells and hepatotropic viruses by preventing their elimination by the immune system. …
Literature
1.
go back to reference Carambia A, Freund B, Schwinge D, Bruns OT, Salmen SC, Ittrich H, Reimer R, Heine M, Huber S, Waurisch C, Eychmüller A, Wraith DC, Korn T, Nielsen P, Weller H, Schramm C, Lüth S, Lohse AW, Heeren J, Herkel J (2015) Nanoparticle-based autoantigen delivery to Treg-inducing liver sinusoidal endothelial cells enables control of autoimmunity in mice. J Hepatol 62(6):1349–1356CrossRef Carambia A, Freund B, Schwinge D, Bruns OT, Salmen SC, Ittrich H, Reimer R, Heine M, Huber S, Waurisch C, Eychmüller A, Wraith DC, Korn T, Nielsen P, Weller H, Schramm C, Lüth S, Lohse AW, Heeren J, Herkel J (2015) Nanoparticle-based autoantigen delivery to Treg-inducing liver sinusoidal endothelial cells enables control of autoimmunity in mice. J Hepatol 62(6):1349–1356CrossRef
6.
go back to reference Oo YH, Ackrill S, Cole R, Jenkins L, Anderson P, Jeffery HC, Jones N, Jeffery LE, Lutz P, Wawman RE, Athwal AK, Thompson J, Gray J, Guo K, Barton D, Hirschfield GM, Wong T, Guest P, Adams DH (2019) Liver homing of clinical grade Tregs after therapeutic infusion in patients with autoimmune hepatitis. JHEP Rep 1(4):286–296CrossRef Oo YH, Ackrill S, Cole R, Jenkins L, Anderson P, Jeffery HC, Jones N, Jeffery LE, Lutz P, Wawman RE, Athwal AK, Thompson J, Gray J, Guo K, Barton D, Hirschfield GM, Wong T, Guest P, Adams DH (2019) Liver homing of clinical grade Tregs after therapeutic infusion in patients with autoimmune hepatitis. JHEP Rep 1(4):286–296CrossRef
9.
go back to reference Liwinski T, Zenouzi R, John C, Ehlken H, Rühlemann MC, Bang C, Groth S, Lieb W, Kantowski M, Andersen N, Schachschal G, Karlsen TH, Hov JR, Rösch T, Lohse AW, Heeren J, Franke A, Schramm C (2020) Alterations of the bile microbiome in primary sclerosing cholangitis. Gut 69(4):665–672CrossRef Liwinski T, Zenouzi R, John C, Ehlken H, Rühlemann MC, Bang C, Groth S, Lieb W, Kantowski M, Andersen N, Schachschal G, Karlsen TH, Hov JR, Rösch T, Lohse AW, Heeren J, Franke A, Schramm C (2020) Alterations of the bile microbiome in primary sclerosing cholangitis. Gut 69(4):665–672CrossRef
11.
go back to reference Nakamoto N, Sasaki N, Aoki R, Miyamoto K, Suda W, Teratani T, Suzuki T, Koda Y, Chu PS, Taniki N, Yamaguchi A, Kanamori M, Kamada N, Hattori M, Ashida H, Sakamoto M, Atarashi K, Narushima S, Yoshimura A, Honda K, Sato T, Kanai T (2019) Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis. Nat Microbiol 4(3):492–503CrossRef Nakamoto N, Sasaki N, Aoki R, Miyamoto K, Suda W, Teratani T, Suzuki T, Koda Y, Chu PS, Taniki N, Yamaguchi A, Kanamori M, Kamada N, Hattori M, Ashida H, Sakamoto M, Atarashi K, Narushima S, Yoshimura A, Honda K, Sato T, Kanai T (2019) Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis. Nat Microbiol 4(3):492–503CrossRef
Metadata
Title
Tolerance and autoimmunity in the liver
Authors
Christoph Schramm
Ye H. Oo
Ansgar W. Lohse
Publication date
01-07-2022
Publisher
Springer Berlin Heidelberg
Published in
Seminars in Immunopathology / Issue 4/2022
Print ISSN: 1863-2297
Electronic ISSN: 1863-2300
DOI
https://doi.org/10.1007/s00281-022-00952-6

Other articles of this Issue 4/2022

Seminars in Immunopathology 4/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.